POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 128 participants.

Also called NCT07469722

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 128 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07469722
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07469722. Randomized; single masking; primary purpose treatment. Start 2026-03-23 (anticipated); primary completion 2028-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure
Acronym
POINTER-HF
Condition
Acute Heart Failure (AHF)
Condition
Congestive Heart Failure Acute
Condition
Diuretic Effect
Condition
Lung Ultrasonography Score
Condition
Ultrasonography, Doppler
Condition
Point-of-care Ultrasound (POCUS)
Intervention (Drug)
Furosemide 40 Milligrams.
Intervention (Drug)
Furosemide 40 Milligrams.
Intervention (Drug)
Hydrochlorothiazide (HCTZ) 25 milligrams.
Intervention (Drug)
Acetazolamide 250 milligrams.
Intervention (Drug)
Dapagliflozin (10mg Tab)
Intervention (Drug)
Potassium Chloride Oral Product
Lead sponsor
Hospital de Clinicas de Porto Alegre (class: other)

Record details

Record id
cardio:ct-nct07469722
Content hash
6a70acb62405f563de4d53fd520e00fa590f4fa574157873d5fc83004870f188